As of April 16, 2025, Cosmo Pharmaceuticals (C43.F) has a market cap of $0.94 billion USD. According to our data, Cosmo Pharmaceuticals is ranked No.5132 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.94 B |
-23.57%
|
Dec 30, 2024 | $1.22 B |
27.39%
|
Dec 29, 2023 | $0.96 B |
-10.21%
|
Dec 30, 2022 | $1.07 B |
1.94%
|
Dec 30, 2021 | $1.05 B |
-19.48%
|
Dec 30, 2020 | $1.30 B |
10.79%
|
Dec 30, 2019 | $1.18 B |
-11.13%
|
Dec 28, 2018 | $1.32 B |
-36.96%
|
Dec 29, 2017 | $2.10 B |
-20.44%
|
Dec 30, 2016 | $2.64 B |
7.94%
|
Dec 30, 2015 | $2.45 B |
947.13%
|
Dec 30, 2014 | $0.23 B |
0.00%
|
Dec 30, 2013 | $0.23 B |
0.00%
|
Dec 28, 2012 | $0.23 B |
0.00%
|
Dec 30, 2011 | $0.23 B |
0.00%
|
Dec 30, 2010 | $0.23 B |
22.41%
|
Dec 30, 2009 | $0.19 B |
11.75%
|
Dec 30, 2008 | $0.17 B |
-19.10%
|
Dec 28, 2007 | $0.21 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
![]() Japan
|
![]() Ironwood Pharmaceuticals
IRWD
|
$0.12 B |
-0.000 M
|
![]() USA
|
![]() Bausch Health
BHC
|
$1.67 B |
-0.000 M
|
![]() Canada
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
Market Cap | = | C43.F Stock Price | * | C43.F Shares Outstanding |
= | $58.21 | * | 16.02 M | |
= | $0.94 B |